Digital health firm Altibbi raises Rs 334 crore in series B round
Advertisement
Dubai: Altibbi, a Middle East digital health platform founded in Jordan and headquartered in Dubai, has raised $44 million in a series B round to expand its online pharmacy and diagnostic collection business, it said in a statement on Monday.
The funding round was led by Dubai-headquartered Foundation Holdings and the venture capital arm of Hikma Pharmaceuticals, Hikma Ventures, as well as existing investors Dubai-based Global Ventures and Amman-based DASH Ventures.
"Our objective is to support Altibbi to reach a superior position where its quality, exponential growth and trusted brand will enable them to be the first publicly listed digital health unicorn IPO in the GCC," Foundation Holdings Chief Executive Abhishek Sharma said in the statement, referring to the six-nation Gulf Cooperation Council.
Other Altibbi shareholders include Endeavor Catalyst, Middle East Venture Partners and Al Rashed, the firm said. Investment bank Awad Capital advised Altibbi on the fundraising.
Foundation Holdings senior advisor Jason Kothari will join Altibbi's board, Altibbi said.
Read also: Tata Capital Healthcare Fund raises Rs 955 crore fund
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.